# TBF Genie Tissulaire clinical trials: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials with TBF Genie Tissulaire as lead sponsor, 3 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by TBF Genie Tissulaire: 20 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/tbf-genie-tissulaire

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 3
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 27, 2026 | NCT07435571 | Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of Trapeziometacarpal Osteoarthritis | TBF Genie Tissulaire | Phase 2 | Recruiting | Trapeziometacarpal Osteoarthritis | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07435571) |
| December 9, 2024 | NCT06723782 | Surgical Release of Hand Tendons With Wrapping of the Released Tendon Using an Amniotic Membrane | TBF Genie Tissulaire | Phase 2 | Completed | Tendon Adhesion, Tenolysis | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06723782) |
| November 7, 2024 | NCT06678984 | Treated Umbilical Vein Allograft (UVT) Versus Autologous Fascial Pubovaginal Sling in the Treatment of Female Stress Urinary Incontinence | TBF Genie Tissulaire | Phase 3 | Recruiting | Stress Urinary Incontinence in Women | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06678984) |
| June 10, 2024 | NCT06450470 | Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus | TBF Genie Tissulaire | Phase 3 | Recruiting | Progressive Keratoconus | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06450470) |
| September 14, 2023 | NCT06038331 | Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis | TBF Genie Tissulaire | Phase 2 | Active not recruiting | Osteoarthritis Hand | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06038331) |
| September 13, 2023 | NCT06034262 | Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis | TBF Genie Tissulaire | Phase 2 | Terminated | Osteoarthritis Hand | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06034262) |
| December 6, 2022 | NCT05638139 | Treatment of Ano-perineal Fistulas Resistant to Surgical Treatment with a Gel and Plug of Wharton's Jelly | TBF Genie Tissulaire | Phase 1 | Completed | Anal Fistula | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05638139) |
| March 31, 2022 | NCT05302609 | Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface | TBF Genie Tissulaire | Phase 2 | Terminated | Scleral Thinning | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05302609) |
| February 22, 2022 | NCT05250726 | Use of a Treated, Devitalized and Sterile Meniscus Segment (MENISC-T) in the Treatment of Scaphotrapeziotrapezoid Osteoarthritis | TBF Genie Tissulaire | Phase 2 | Completed | Osteoarthritis Hand | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05250726) |
| February 22, 2022 | NCT05250583 | Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis | TBF Genie Tissulaire | Phase 2 | Terminated | Keratitis | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05250583) |
| February 21, 2022 | NCT05247658 | Use of a Disk of Amniotic Membrane (Visio-AMTRIX) in Postoperative Care After PKR | TBF Genie Tissulaire | Phase 3 | Terminated | Myopia, Astigmatism, Hypermetropia | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05247658) |
| February 11, 2022 | NCT05236049 | Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant | TBF Genie Tissulaire | Phase 1 | Completed | Enucleated; Eye, Eye Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05236049) |
| January 26, 2022 | NCT05207189 | Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications | TBF Genie Tissulaire | Phase 2 | Completed | Female Stress Incontinence, Stress Urinary Incontinence | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05207189) |
| January 20, 2022 | NCT05200000 | Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis | TBF Genie Tissulaire | Phase 1 | Completed | Keratitis, Ulcerative, Corneal Ulcer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05200000) |
| January 20, 2022 | NCT05199155 | Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist | TBF Genie Tissulaire | Phase 2 | Terminated | Nerve Injury, Nerve Lesion | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05199155) |
| January 13, 2022 | NCT05191628 | Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole | TBF Genie Tissulaire | Phase 2 | Terminated | Macular Holes, Retinal Detachment | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05191628) |
| December 29, 2021 | NCT05172349 | Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers | TBF Genie Tissulaire | Phase 2 | Withdrawn | Corneal Ulcer, Persistent Corneal Epithelial Defect | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05172349) |
| April 13, 2016 | NCT02736318 | OD-PHOENIX in Talus Osteochondral Lesion | TBF Genie Tissulaire | Phase 1/2 | Terminated | Talus Osteochondral Defect | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02736318) |
| April 30, 2015 | NCT02430558 | Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft | TBF Genie Tissulaire | Phase 1/2 | Terminated | Cartilage Injury | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02430558) |
| July 24, 2009 | NCT00945399 | Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions | TBF Genie Tissulaire | Phase 3 | Terminated | Knee Chondral, Osteochondral Defect | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00945399) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 3 |
| Phase 1/2 | 2 |
| Phase 2 | 11 |
| Phase 3 | 4 |

## By status

| Status | Trials |
| --- | --- |
| Terminated | 9 |
| Completed | 6 |
| Recruiting | 3 |
| Active not recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Corneal Ulcer | 2 |
| Osteoarthritis | 1 |
| Eye Neoplasms | 1 |
| Keratitis | 1 |
| Rectal Fistula | 1 |
| Myopia | 1 |
| Astigmatism | 1 |
| Hyperopia | 1 |
| Retinal Perforations | 1 |
| Retinal Detachment | 1 |
| Urinary Incontinence, Stress | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Internet service providers in the United States](https://specstream.ai/data/businesses/internet-service-providers/united-states)
- [Puerto Rican restaurants in the United States](https://specstream.ai/data/businesses/puerto-rican-restaurants/united-states)
- [Ambulance services in the United States](https://specstream.ai/data/businesses/ambulance-services/united-states)
- [Dim sum restaurants in the United States](https://specstream.ai/data/businesses/dim-sum-restaurants/united-states)
- [Jewelry manufacturers in the United States](https://specstream.ai/data/businesses/jewelry-manufacturers/united-states)
- [Restaurant wholesale companies in the United States](https://specstream.ai/data/businesses/restaurant-wholesale-companies/united-states)
